Myositissyndrome

Zurück zum Zitat Wiendl H, Schmidt J et al (2022) Myositissyndrome, S2k-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie (www.dgn.org/leitlinien) Wiendl H, Schmidt J et al (2022) Myositissyndrome, S2k-Leitlinie. In: Deutsche Gesellschaft für Neurologie (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie (www.​dgn.​org/​leitlinien)

Zurück zum Zitat Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https://doi.org/10.1038/s41572-021-00321-xCrossRef Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, Mammen AL, Miller FW (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86. https://​doi.​org/​10.​1038/​s41572-021-00321-xCrossRef

Zurück zum Zitat Trallero-Araguás E, Rodrigo-Pendás J, Selva-O’Callaghan A, Martínez-Gómez X, Bosch X, Labrador-Horrillo M, Grau-Junyent JM, Vilardell-Tarrés M (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64(2):523–532. https://doi.org/10.1002/art.33379CrossRef Trallero-Araguás E, Rodrigo-Pendás J, Selva-O’Callaghan A, Martínez-Gómez X, Bosch X, Labrador-Horrillo M, Grau-Junyent JM, Vilardell-Tarrés M (2012) Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum 64(2):523–532. https://​doi.​org/​10.​1002/​art.​33379CrossRef

Zurück zum Zitat Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N (2016) Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28(6):636–644. https://doi.org/10.1097/bor.0000000000000329CrossRef Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N (2016) Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 28(6):636–644. https://​doi.​org/​10.​1097/​bor.​0000000000000329​CrossRef

Zurück zum Zitat Day J, Otto S, Cash K, Limaye V (2020) Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study. Neuromuscul Disord 30(3):186–199. https://doi.org/10.1016/j.nmd.2020.02.003CrossRef Day J, Otto S, Cash K, Limaye V (2020) Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study. Neuromuscul Disord 30(3):186–199. https://​doi.​org/​10.​1016/​j.​nmd.​2020.​02.​003CrossRef

Zurück zum Zitat Pinal-Fernandez I, Casal-Dominguez M, Mammen AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20(4):21. https://doi.org/10.1007/s11926-018-0732-6CrossRef Pinal-Fernandez I, Casal-Dominguez M, Mammen AL (2018) Immune-mediated necrotizing myopathy. Curr Rheumatol Rep 20(4):21. https://​doi.​org/​10.​1007/​s11926-018-0732-6CrossRef

Zurück zum Zitat Cavagna L, Nuno L, Scire CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castaneda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airo P, Cavazzana I, Martinez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, Gonzalez-Gay MA (2017) Serum Jo‑1 autoantibody and isolated arthritis in the antisynthetase syndrome: Review of the literature and report of the experience of AENEAS collaborative group. Clin Rev Allergy Immunol 52(1):71–80. https://doi.org/10.1007/s12016-016-8528-9CrossRef Cavagna L, Nuno L, Scire CA, Govoni M, Longo FJ, Franceschini F, Neri R, Castaneda S, Sifuentes Giraldo WA, Caporali R, Iannone F, Fusaro E, Paolazzi G, Pellerito R, Schwarting A, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Bartoloni E, Specker C, Pina Murcia T, La Corte R, Furini F, Foschi V, Bachiller Corral J, Airo P, Cavazzana I, Martinez-Barrio J, Hinojosa M, Giannini M, Barsotti S, Menke J, Triantafyllias K, Vitetta R, Russo A, Bogliolo L, Bajocchi G, Bravi E, Barausse G, Bortolotti R, Selmi C, Parisi S, Salaffi F, Montecucco C, Gonzalez-Gay MA (2017) Serum Jo‑1 autoantibody and isolated arthritis in the antisynthetase syndrome: Review of the literature and report of the experience of AENEAS collaborative group. Clin Rev Allergy Immunol 52(1):71–80. https://​doi.​org/​10.​1007/​s12016-016-8528-9CrossRef

Zurück zum Zitat Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, De Paepe B, deBleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30–39. https://doi.org/10.1136/annrheumdis-2017-211868CrossRef Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, De Paepe B, deBleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30–39. https://​doi.​org/​10.​1136/​annrheumdis-2017-211868CrossRef

Zurück zum Zitat Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA (2014) Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 83(5):426–433. https://doi.org/10.1212/wnl.0000000000000642CrossRef Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA (2014) Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 83(5):426–433. https://​doi.​org/​10.​1212/​wnl.​0000000000000642​CrossRef

Zurück zum Zitat Tomaras S, Kekow J, Feist E (2021) Idiopathische inflammatorische Myopathien: Aktuelles zu Diagnose und Klassifikation. Akt Rheumatol 46(04):361–372CrossRef Tomaras S, Kekow J, Feist E (2021) Idiopathische inflammatorische Myopathien: Aktuelles zu Diagnose und Klassifikation. Akt Rheumatol 46(04):361–372CrossRef

Zurück zum Zitat Allenbach Y, Benveniste O, Stenzel W, Boyer O (2020) Immune-mediated necrotizing myopathy: Clinical features and pathogenesis. Nat Rev Rheumatol 16(12):689–701. https://doi.org/10.1038/s41584-020-00515-9CrossRef Allenbach Y, Benveniste O, Stenzel W, Boyer O (2020) Immune-mediated necrotizing myopathy: Clinical features and pathogenesis. Nat Rev Rheumatol 16(12):689–701. https://​doi.​org/​10.​1038/​s41584-020-00515-9CrossRef

Zurück zum Zitat Olthoff A, Carstens PO, Zhang S, von Fintel E, Friede T, Lotz J, Frahm J, Schmidt J (2016) Evaluation of dysphagia by novel real-time MRI. Neurology 87(20):2132–2138. https://doi.org/10.1212/wnl.0000000000003337CrossRef Olthoff A, Carstens PO, Zhang S, von Fintel E, Friede T, Lotz J, Frahm J, Schmidt J (2016) Evaluation of dysphagia by novel real-time MRI. Neurology 87(20):2132–2138. https://​doi.​org/​10.​1212/​wnl.​0000000000003337​CrossRef

Zurück zum Zitat Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O’Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M (2019) Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study. J Rheumatol 46(3):279–284. https://doi.org/10.3899/jrheum.180355CrossRef Sebastiani M, Triantafyllias K, Manfredi A, González-Gay MA, Palmou-Fontana N, Cassone G, Drott U, Delbrück C, Rojas-Serrano J, Bertolazzi C, Nuño L, Giannini M, Iannone F, Vicente EF, Castañeda S, Selva-O’Callaghan A, Trallero Araguas E, Emmi G, Iuliano A, Bauhammer J, Miehle N, Parisi S, Cavagna L, Codullo V, Montecucco C, Lopez-Longo FJ, Martínez-Barrio J, Nieto-González JC, Vichi S, Confalonieri M, Tomietto P, Bergner R, Sulli A, Bonella F, Furini F, Scirè CA, Bortoluzzi A, Specker C, Barsotti S, Neri R, Mosca M, Caproni M, Weinmann-Menke J, Schwarting A, Smith V, Cutolo M (2019) Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study. J Rheumatol 46(3):279–284. https://​doi.​org/​10.​3899/​jrheum.​180355CrossRef

Zurück zum Zitat Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O’Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R (2021) A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford) 60(6):2615–2628. https://doi.org/10.1093/rheumatology/keab166CrossRef Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O’Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R (2021) A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford) 60(6):2615–2628. https://​doi.​org/​10.​1093/​rheumatology/​keab166CrossRef

Zurück zum Zitat Marago I, Lilleker JB, Chinoy H (2022) The perils of myositis mimickers with illustrative case reports. Clin Exp Rheumatol 40(2):366–372. https://doi.org/10.55563/clinexprheumatol/21xrzfCrossRef Marago I, Lilleker JB, Chinoy H (2022) The perils of myositis mimickers with illustrative case reports. Clin Exp Rheumatol 40(2):366–372. https://​doi.​org/​10.​55563/​clinexprheumatol​/​21xrzfCrossRef

Zurück zum Zitat Kassner U, Grunwald S, Spira D, Buchmann N, Bobbert T, Gazzerro E, Hollstein T, Spuler S, Steinhagen-Thiessen E (2021) Diagnostics and treatment of statin-associated muscle symptoms. Internist (Berl) 62(8):827–840. https://doi.org/10.1007/s00108-021-01059-0CrossRef Kassner U, Grunwald S, Spira D, Buchmann N, Bobbert T, Gazzerro E, Hollstein T, Spuler S, Steinhagen-Thiessen E (2021) Diagnostics and treatment of statin-associated muscle symptoms. Internist (Berl) 62(8):827–840. https://​doi.​org/​10.​1007/​s00108-021-01059-0CrossRef

Zurück zum Zitat Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65(2):314–324. https://doi.org/10.1002/art.37754CrossRef Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65(2):314–324. https://​doi.​org/​10.​1002/​art.​37754CrossRef

Zurück zum Zitat Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718–1727. https://doi.org/10.1056/NEJMoa1908681CrossRef Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718–1727. https://​doi.​org/​10.​1056/​NEJMoa1908681CrossRef

Zurück zum Zitat Aggarwal R, Charles-Schoeman C, Schessl J, Dimachkie MM, Beckmann I, Levine T (2021) Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10 % in patients with dermatomyositis („ProDERM Study“). Medicine (Baltimore) 100(1):e23677. https://doi.org/10.1097/md.0000000000023677CrossRef Aggarwal R, Charles-Schoeman C, Schessl J, Dimachkie MM, Beckmann I, Levine T (2021) Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10 % in patients with dermatomyositis („ProDERM Study“). Medicine (Baltimore) 100(1):e23677. https://​doi.​org/​10.​1097/​md.​0000000000023677​CrossRef

Zurück zum Zitat Benveniste O, Hogrel J‑Y, Belin L, Annoussamy M, Bachasson D et al (2021) Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Lancet Rheumatol 3(1):e40–e48. https://doi.org/10.1016/S2665-9913(20)30280-0.hal-03180889CrossRef Benveniste O, Hogrel J‑Y, Belin L, Annoussamy M, Bachasson D et al (2021) Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial. Lancet Rheumatol 3(1):e40–e48. https://​doi.​org/​10.​1016/​S2665-9913(20)30280-0.​hal-03180889CrossRef

Zurück zum Zitat Misse RG, Borges IBP, Dos Santos AM, Gupta L, Shinjo SK (2021) Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review. Autoimmun Rev 20(10):102897. https://doi.org/10.1016/j.autrev.2021.102897CrossRef Misse RG, Borges IBP, Dos Santos AM, Gupta L, Shinjo SK (2021) Effect of exercise training on fatigue and pain in patients with systemic autoimmune myopathies: A systematic review. Autoimmun Rev 20(10):102897. https://​doi.​org/​10.​1016/​j.​autrev.​2021.​102897CrossRef